Showing 1 posts of 1 posts found.
NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO